Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Hubbert

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Infectious Diseases|December 1, 1995
Divergent human papillomavirus type 16 variants are serologically cross-reactiveG Cheng, J P Icenogle, R Kirnbauer, et al.
International Journal of Cancer|December 11, 1996
Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populationsB Nonnenmacher, S Kruger Kjaer, E I Svare, et al.
The Journal of Infectious Diseases|October 23, 1997
Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk womenE I Svare, S K Kjaer, B Nonnenmacher, et al.
Journal of Clinical Microbiology|July 1, 1997
Interlaboratory agreement among results of human papillomavirus type 16 enzyme-linked immunosorbent assaysH D Strickler, A Hildesheim, R P Viscidi, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Infectious Diseases|December 1, 1995
Divergent human papillomavirus type 16 variants are serologically cross-reactiveG Cheng, J P Icenogle, R Kirnbauer, et al.
International Journal of Cancer|December 11, 1996
Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populationsB Nonnenmacher, S Kruger Kjaer, E I Svare, et al.
The Journal of Infectious Diseases|October 23, 1997
Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk womenE I Svare, S K Kjaer, B Nonnenmacher, et al.
Journal of Clinical Microbiology|July 1, 1997
Interlaboratory agreement among results of human papillomavirus type 16 enzyme-linked immunosorbent assaysH D Strickler, A Hildesheim, R P Viscidi, et al.
Pageof 3